Differential serum interferon-β levels in autoimmune thyroid diseases

Area of Science:

• Endocrinology
• Immunology
• Thyroid Research

Background:

• Interferon (IFN)-β is a known environmental trigger for autoimmune thyroid disease (AITD).
• The specific association of another type-1 interferon, IFN-β, with AITD remains largely unknown.
• Understanding the role of IFN-β in AITD pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the association between serum IFN-β levels and AITD in a Taiwanese population.
• To explore the relationship of IFN-β with thyroid function, thyroid-stimulating hormone receptor antibody (TSHRAb), and B-cell activating factor (BAFF) levels.
• To determine if these associations are gender-specific.

Main Methods:

• A case-control study involving 160 patients with Graves' disease (GD), 47 with Hashimoto's thyroiditis (HT), and 119 healthy controls.
• Quantification of serum IFN-β and BAFF levels.
• Measurement of thyroid function and TSHRAb levels at the time of serum collection.

Main Results:

• Serum IFN-β levels were significantly lower in patients with HT compared to controls (p = 0.031).
• A significant inverse correlation between IFN-β and TSHRAb was observed in men with GD (r = -0.433, p = 0.044).
• Serum IFN-β levels showed a negative association with BAFF levels in men across GD, HT, and overall AITD cohorts, but not in women.

Conclusions:

• Lower serum IFN-β levels are associated with Hashimoto's thyroiditis.
• The correlations between IFN-β, TSHRAb, and BAFF in autoimmune thyroid disease are gender-specific.
• Further large-scale studies are warranted to validate these gender-specific findings and elucidate the precise role of IFN-β in AITD.